ACS Medicinal Chemistry Letters · 2012 · 12 citations · 18 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryLead OptimizationEnzyme InhibitionSteroid Hormone BiochemistrySteroid MetabolismSteroid Pharmacology11 Beta-hydroxylase11 Beta-hydroxysteroid DehydrogenaseChemical Scaffold HoppingHydroxysteroid DehydrogenasesIn Vivo StudiesSteroid Hormone Biosynthesis InhibitionSteroid Hormone Biosynthesis InhibitorsSteroid Hormone Pharmacology
On the basis of scaffold hopping, a novel series of 2-alkyl-1-arylsulfonylprolinamides was discovered as 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1) inhibitors. A representative compound 4ek, obtained through SAR and structure optimization studies, demonstrates excellent in vitro potency against 11β-HSD-1 and dose-dependent in vivo inhibition of 11β-HSD-1 in a prednisone/prednisolone transformation biomarker study in mice.
18
Edwin B. Villhauer, J. A. Brinkman, Goli B. Naderi et al. · Journal of Medicinal Chemistry · 2003 · 613 citations · Full text
Julio Rosenstock, Salomon Banarer, Vivian Fonseca et al. · Diabetes Care · 2010 · 314 citations · Full text
Tjeerd Barf, Jerk Vallgårda, Rikard Emond et al. · Journal of Medicinal Chemistry · 2002 · 211 citations · Full text